Mario Strazzabosco MD, PhD

Transcription

1 Mario Strazzabosco MD, PhD Professor of Medicine & Gastroenterology Deputy Director, Yale Liver Center, Director, Hepatobiliary Cancer Program Yale University School of Medicine Director Master Program in Transplant Medicine Scientific Director CeLiveR Network University of Milan-Bicocca

2 Defining features of PSC Bile duct damage with portal inflamma;on and peribiliary sclerosis Segmental bile ducts sclerosis and beading Associa;on with IBD PSC INFLAMMATORY BOWEL DISEASE

3 PSC histology

4 Progressive biliary damage in PSC PSC stage III PSC stage II PSC stage IV

5 Biology of cholangiocytes Bile hydration and alkalinization Reactivity Stem cell potential

6 Ductules or Cholangioles Hepatocytes Small Bile Duct Canal of Hering Small Cholangiocytes Lumen Large Cholangiocytes Secretin CFTR PKA ATP SR Duodenum Large Bile Duct camp Na - ATP HCO3- H 2O TGR5 Cl- ClK+ N a+ + H 2O Cl ClCa Ca2+ ClHCO3- Na + P2Y2 H+

7 Cholangiopathies result from the epithelial reac;on to liver damage and its repair/regenera;on acempts Inflammation Fibrosis Cholestasis Cholangiocyte Death (Lytic or Apoptotic) Reactive Proliferation of cholangiocytes Neoplastic transformation

8 Auto / Allo Immunity (i.e., PBC, OLT rejection) Xenobiotics (i.e., 5-fluouracil) Exotoxins / Infection (i.e., bacterial antigens) Endotoxins (i.e., bile acids) Initial Insult to Biliary Epithelial Cells Genetic Defects (i.e.,cf, MDR3 defect) Inflammatory Response resolution Chronic Inflammation persistence/progression Cholestasis Ductopenia BileDuct Proliferation Fibrosis Malignant Transformation Lazaridis, Strazzabosco and LaRusso, Gastroenterology 2004

9 Gene;c Cholangiopathies are the RoseCa Stone CF cholangiopathy Alagille ADPKD Inversin and biliary atresia Claudin and PSC Gene;c Cholangiop athies CHF Caroli Disease MDR3 deficency

10 Cystic Fibrosis- causes a progressive sclerosing cholangiopathy in a subset of patients H 2 O Cl - Chronic cholestasis predisposes the biliary epithelium to damages

11 Fibrosing cholangiopathies in Systemic conditions PSC INFLAMMATORY BOWEL DISEASE Liver Disease Cystic Fibrosis A two hit phenomenon?

12 Altered Innate Immunity Response of the Biliary Epithelium to portal endotoxins cause bilairy disease in Cys;c Fibrosis CFTR KO mice possess the bile secretory defect of Cys;c Fibrosis, but do not develop liver disease Experimental coli;s generates liver disease in CFTR KO mice, but not in their normal licermate Liver disease caused by coli;s in CFTR KO animals does not improve when bile secre;on is restore using therapeu;c bile acids Cholangiocytes isolated from CFTR KO mice present an exaggerated inflammatory response to endoxin Toll like receptor 4 pathway is ac;vated with loss of the normal endotoxin tolerance R. Fiorotto, M. Strazzabosco, EASL meeting 2010

13 Biliary epithelium protects against pathogens by expressing Toll like receptors (TLRs) (Szabo G. et al., Hepatology 2006) TLRs belong to a family of protein that recognize and discriminate between specific paaerns of microbial components (i.e. LPS, DNA, RNA, flagellin) In normal condikons a process of endotoxin tolerance prevents excessive inflammakon IN CysKc Fibrosis, CFTR deficiency causes a loss of endotoxin tolerance and in the presence of a second hit, such as coliks, the dysregulated inflammatory response causes liver disease

14 Hypothesis: a second hit may in part explain of PSC pathogenesis Leaky gut mucosa Bacterial constituents are delivered into the portal circulation Cholangiocyte T-cell An inflammatory response is triggered in conditions where endotoxin tolerance is decreased because of a cholangiocyte dysfunction (such as CFTR deficiency, or TGR5 or Gllypican 6, etc)

15 Cellular Cross-talk in Cholangiopathies Reactive Cholangiocytes PMN IL-8 Kupffer cell MCP-1 IL-1, IL-6 TNFa NO IFN γ IL-8 HGF ET-1 PDGF-BB TGF-β2 NO CTGF HGF ET-1 IL-6 T-cell Quiescent stellate cell Portal fibroblast Activated stellate cell or myofibroblast Reparative events of liver damage Liver Fibrosis

16 Cholangiocyte inos and Nitrotyrosine are increased in Primary Sclerosing Cholangitis inos 3-Nitrotyrosine Secretin AC camp Cl- RNOS Endotoxins Cytokines NO. inos ClHCO 3

17 PSC Partners Seeking a Care For all those whose care is our concern, the work goes on, the cause endures, the hope is real, and the dream shall come true Modified from Edward Kennedy, 1980